An assay that measures C1 inhibitor (C1-INH) activity on a dried blood spot after a blood sample is blotted onto…
Articles by Margarida Maia, PhD
Pharvaris plans a trial of deucrictibant to treat acquired angioedema this year, following promising data showing the…
Garadacimab appears to be safe for long-term use as prophylaxis, or preventive treatment, reducing the frequency of swelling attacks…
Many people with hereditary angioedema (HAE) delay on-demand treatment for their attacks because they think the swelling isn’t severe…
People with hereditary angioedema (HAE) who have normal C1-inhibitor (C1-INH)Â levels and activity appear to have more active disease and…
Transitioning from other prophylactic, or preventive, treatments, to Orladeyo (berotralstat) or Takhzyro (lanadelumab) can take some time and…
Switching to Orladeyo (berotralstat) may help reduce the frequency and duration of swelling attacks in people with hereditary…
An immediate-release capsule of deucrictibant that’s being developed by Pharvaris continues to show promise as an on-demand and preventive…
A young woman who developed angioedema of the small bowel after taking two different angiotensin-converting enzyme (ACE) inhibitors showed…
A man in Japan may have developed acquired angioedema as a late complication of graft-versus-host disease, which occurred when…